Cantitate/Preț
Produs

Development of Novel Anti-HIV Pyrimidobenzothiazine Derivatives (Springer Theses)

De (autor)
Notă GoodReads:
en Limba Engleză Carte Hardback – 17 Oct 2013
The author successfully developed novel anti-HIV PD 404182 derivatives that exhibited submicromolar inhibitory activity against both HIV-1 and HIV-2. His thesis is in three parts. The first part expounds efficient methods for the synthesis of tricyclic heterocycles related to PD 404182 based on the sp2-carbon−heteroatom bond formations. Starting from arene or haloarene, C-O, C-N, or C-S bonds were formed by simply changing the reactants. These synthetic methods provide powerful approaches for the divergent preparation of pyrimido-benzoxazine, -quinazoline, or -benzothiazine derivatives. The second part explains SAR studies of PD 404182 for the development of anti-HIV agents. Through optimization studies of the central 1,3-thiazin-2-imine core, the benzene and cyclic amidine ring parts, 3-fold more potent inhibitors were obtained compared with the lead compound. The author also reveals by a time-of-drug-addition experiment that PD 404182 derivatives impaired HIV replication at the binding or fusion stage. The third part of the thesis elucidates the development of photoaffinity probes for the target identification of PD 404182. By the photolabeling experiment of HIV-1-infected H9 cells using these probes, the author detected proteins specifically bound to PD 404182. These new anti-HIV agents may be promising agents for anti-HIV therapy because their mechanisms of action differ from those of the currently approved anti-HIV agents.
Citește tot Restrânge
Toate formatele și edițiile
Toate formatele și edițiile Preț Express
Carte Paperback (1) 34782 lei  Economic 36-50 zile +13987 lei  11-19 zile
  Springer – 23 Aug 2016 34782 lei  Economic 36-50 zile +13987 lei  11-19 zile
Carte Hardback (1) 44154 lei  Economic 36-50 zile +7976 lei  5-12 zile
  Springer – 17 Oct 2013 44154 lei  Economic 36-50 zile +7976 lei  5-12 zile

Din seria Springer Theses

Preț: 44154 lei

Preț vechi: 46972 lei
-6%

Puncte Express: 662

Preț estimativ în valută:
8800 9764$ 7436£

Carte tipărită la comandă

Livrare economică 13-27 ianuarie 20
Livrare express 13-20 decembrie pentru 8975 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9784431544449
ISBN-10: 4431544445
Pagini: 100
Ilustrații: 95 schwarz-weiße und 3 farbige Abbildungen
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.42 kg
Ediția: 2013
Editura: Springer
Colecția Springer
Seria Springer Theses

Locul publicării: Tokyo, Japan

Public țintă

Research

Cuprins

Introduction.- Development of Divergent Synthetic Methods of Pyrimidobenzothiazine and Related Tricyclic Heterocycles.- Structure-Activity Relationship Study of PD 404182 Derivatives for the Highly Potent Anti-HIV Agents.- Design and Synthesis of Photoaffinity Probes and their Application to Target Identification Study of PD 404182.- Conclusions.

Notă biografică

Department of Chemistry
University of Massachusetts Amherst, USA
Ph. D. in Pharmaceutical Sciences
Graduate School of Pharmaceutical Sciences,
Kyoto University, Japan

Textul de pe ultima copertă

The author successfully developed novel anti-HIV PD 404182 derivatives that exhibited submicromolar inhibitory activity against both HIV-1 and HIV-2. His thesis is in three parts. The first part expounds efficient methods for the synthesis of tricyclic heterocycles related to PD 404182 based on the sp2-carbon−heteroatom bond formations. Starting from arene or haloarene, C-O, C-N, or C-S bonds were formed by simply changing the reactants. These synthetic methods provide powerful approaches for the divergent preparation of pyrimido-benzoxazine, -quinazoline, or -benzothiazine derivatives. The second part explains SAR studies of PD 404182 for the development of anti-HIV agents. Through optimization studies of the central 1,3-thiazin-2-imine core, the benzene and cyclic amidine ring parts, 3-fold more potent inhibitors were obtained compared with the lead compound. The author also reveals by a time-of-drug-addition experiment that PD 404182 derivatives impaired HIV replication at the binding or fusion stage. The third part of the thesis elucidates the development of photoaffinity probes for the target identification of PD 404182. By the photolabeling experiment of HIV-1-infected H9 cells using these probes, the author detected proteins specifically bound to PD 404182. These new anti-HIV agents may be promising agents for anti-HIV therapy because their mechanisms of action differ from those of the currently approved anti-HIV agents.

Caracteristici

Nominated by Kyoto University as an outstanding Ph.D. thesis
Divergent synthetic methods that enable efficient structure–activity relationship studies
Development of more potent derivatives based on extensive structure-activity relationship studies